vs

Side-by-side financial comparison of MOVING iMAGE TECHNOLOGIES INC. (MITQ) and NovaBay Pharmaceuticals, Inc. (NBY). Click either name above to swap in a different company.

NovaBay Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($4.8M vs $3.8M, roughly 1.3× MOVING iMAGE TECHNOLOGIES INC.). MOVING iMAGE TECHNOLOGIES INC. runs the higher net margin — -10.2% vs -25.5%, a 15.3% gap on every dollar of revenue. On growth, NovaBay Pharmaceuticals, Inc. posted the faster year-over-year revenue change (126.1% vs 10.2%). Over the past eight quarters, NovaBay Pharmaceuticals, Inc.'s revenue compounded faster (42.5% CAGR vs 7.8%).

Silicon Image Inc. was an American fabless semiconductor company based in Hillsboro, Oregon, and active from 1995 to 2015. The company designed circuits for mobile phones, consumer electronics and personal computers (PCs). It also manufactured wireless and wired connectivity products used for high-definition content. The company's semiconductor and IP products were deployed by manufacturers in devices such as smartphones, tablets, digital televisions (DTVs), and other consumer electronics, as...

NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis

MITQ vs NBY — Head-to-Head

Bigger by revenue
NBY
NBY
1.3× larger
NBY
$4.8M
$3.8M
MITQ
Growing faster (revenue YoY)
NBY
NBY
+115.9% gap
NBY
126.1%
10.2%
MITQ
Higher net margin
MITQ
MITQ
15.3% more per $
MITQ
-10.2%
-25.5%
NBY
Faster 2-yr revenue CAGR
NBY
NBY
Annualised
NBY
42.5%
7.8%
MITQ

Income Statement — Q2 FY2026 vs Q4 FY2024

Metric
MITQ
MITQ
NBY
NBY
Revenue
$3.8M
$4.8M
Net Profit
$-388.0K
$-1.2M
Gross Margin
30.7%
65.2%
Operating Margin
-10.8%
-37.2%
Net Margin
-10.2%
-25.5%
Revenue YoY
10.2%
126.1%
Net Profit YoY
26.4%
70.5%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MITQ
MITQ
NBY
NBY
Q4 25
$3.8M
Q3 25
$5.6M
Q1 25
$3.6M
Q4 24
$3.4M
$4.8M
Q3 24
$5.3M
$0
Q2 24
$6.3M
$2.4M
Q1 24
$3.9M
$2.6M
Q4 23
$3.3M
$2.1M
Net Profit
MITQ
MITQ
NBY
NBY
Q4 25
$-388.0K
Q3 25
$509.0K
Q1 25
$-240.0K
Q4 24
$-527.0K
$-1.2M
Q3 24
$-25.0K
$-1.2M
Q2 24
$-416.0K
$-1.6M
Q1 24
$-601.0K
$-3.2M
Q4 23
$-794.0K
$-4.1M
Gross Margin
MITQ
MITQ
NBY
NBY
Q4 25
30.7%
Q3 25
30.0%
Q1 25
29.8%
Q4 24
27.2%
65.2%
Q3 24
26.1%
Q2 24
22.5%
66.3%
Q1 24
17.4%
68.2%
Q4 23
23.2%
51.5%
Operating Margin
MITQ
MITQ
NBY
NBY
Q4 25
-10.8%
Q3 25
6.3%
Q1 25
-7.6%
Q4 24
-16.3%
-37.2%
Q3 24
-1.3%
Q2 24
-7.3%
-67.4%
Q1 24
-16.7%
-87.1%
Q4 23
-25.4%
-48.0%
Net Margin
MITQ
MITQ
NBY
NBY
Q4 25
-10.2%
Q3 25
9.1%
Q1 25
-6.7%
Q4 24
-15.3%
-25.5%
Q3 24
-0.5%
Q2 24
-6.6%
-66.0%
Q1 24
-15.4%
-122.2%
Q4 23
-24.3%
-195.5%
EPS (diluted)
MITQ
MITQ
NBY
NBY
Q4 25
$-0.04
Q3 25
$0.05
Q1 25
$-0.02
Q4 24
$-0.05
Q3 24
$0.00
$-1.92
Q2 24
$-0.04
$-1.37
Q1 24
$-0.06
$-29.95
Q4 23
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MITQ
MITQ
NBY
NBY
Cash + ST InvestmentsLiquidity on hand
$430.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$5.0M
$-129.0K
Total Assets
$9.5M
$3.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MITQ
MITQ
NBY
NBY
Q4 25
Q3 25
Q1 25
Q4 24
$430.0K
Q3 24
$776.0K
Q2 24
$751.0K
Q1 24
$1.8M
Q4 23
$2.9M
Stockholders' Equity
MITQ
MITQ
NBY
NBY
Q4 25
$5.0M
Q3 25
$5.4M
Q1 25
$5.0M
Q4 24
$5.2M
$-129.0K
Q3 24
$5.7M
$1.1M
Q2 24
$5.7M
$-617.0K
Q1 24
$6.3M
$160.0K
Q4 23
$7.1M
$3.3M
Total Assets
MITQ
MITQ
NBY
NBY
Q4 25
$9.5M
Q3 25
$11.3M
Q1 25
$11.2M
Q4 24
$10.0M
$3.4M
Q3 24
$10.7M
$3.9M
Q2 24
$10.5M
$3.9M
Q1 24
$12.7M
$5.4M
Q4 23
$12.5M
$9.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MITQ
MITQ
NBY
NBY
Operating Cash FlowLast quarter
$-1.6M
$-1.7M
Free Cash FlowOCF − Capex
$-1.7M
FCF MarginFCF / Revenue
-35.4%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MITQ
MITQ
NBY
NBY
Q4 25
$-1.6M
Q3 25
$-167.0K
Q1 25
$53.0K
Q4 24
$70.0K
$-1.7M
Q3 24
$-32.0K
$-2.4M
Q2 24
$-472.0K
$-1.4M
Q1 24
$1.0M
$-2.0M
Q4 23
$-1.2M
$-592.0K
Free Cash Flow
MITQ
MITQ
NBY
NBY
Q4 25
Q3 25
Q1 25
Q4 24
$-1.7M
Q3 24
Q2 24
Q1 24
$-2.0M
Q4 23
$-1.2M
$-595.0K
FCF Margin
MITQ
MITQ
NBY
NBY
Q4 25
Q3 25
Q1 25
Q4 24
-35.4%
Q3 24
Q2 24
Q1 24
-75.3%
Q4 23
-35.8%
-28.3%
Capex Intensity
MITQ
MITQ
NBY
NBY
Q4 25
Q3 25
Q1 25
Q4 24
0.1%
Q3 24
Q2 24
0.0%
0.0%
Q1 24
0.0%
0.1%
Q4 23
0.3%
0.1%
Cash Conversion
MITQ
MITQ
NBY
NBY
Q4 25
Q3 25
-0.33×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MITQ
MITQ

Segment breakdown not available.

NBY
NBY

Other$2.4M51%
Total Product Revenue$2.3M49%

Related Comparisons